CSF3 and diabetes mellitus: It is conceivable that autoimmunity played an important role in graft loss in NOD recipients, since G-CSF/RAPA treatment was inefficient to reverse diabetes or to prolong syngeneic islet graft survival in NOD mice, suggesting that it could not abrogate autoimmunity.